Polarityte Inc (NASDAQ:PTE) Director Steve Gorlin sold 53,700 shares of Polarityte stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $5.94, for a total transaction of $318,978.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

PTE stock traded down $0.09 during midday trading on Wednesday, hitting $5.54. The stock had a trading volume of 245,995 shares, compared to its average volume of 364,007. The stock has a market capitalization of $136.71 million, a P/E ratio of -1.14 and a beta of 1.66. The company has a debt-to-equity ratio of 0.07, a quick ratio of 5.55 and a current ratio of 5.59. Polarityte Inc has a 12-month low of $4.96 and a 12-month high of $41.22.

Polarityte (NASDAQ:PTE) last released its earnings results on Friday, May 10th. The company reported ($1.18) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.01) by ($0.17). The firm had revenue of $1.50 million during the quarter, compared to analysts’ expectations of $1.33 million. Polarityte had a negative return on equity of 86.24% and a negative net margin of 4,259.44%. The firm’s quarterly revenue was up 49900.0% on a year-over-year basis. Research analysts forecast that Polarityte Inc will post -4.32 earnings per share for the current fiscal year.

A number of equities research analysts have recently issued reports on PTE shares. Cantor Fitzgerald set a $65.00 price target on shares of Polarityte and gave the company a “buy” rating in a research report on Tuesday, March 19th. Piper Jaffray Companies set a $30.00 price objective on shares of Polarityte and gave the stock a “buy” rating in a research note on Monday, March 18th. Northland Securities reissued a “buy” rating and set a $50.00 price objective on shares of Polarityte in a research note on Monday, March 18th. Zacks Investment Research raised shares of Polarityte from a “sell” rating to a “hold” rating in a research note on Wednesday, April 10th. Finally, Evercore ISI started coverage on shares of Polarityte in a research note on Wednesday, March 20th. They set an “outperform” rating and a $26.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. Polarityte has an average rating of “Hold” and an average price target of $34.00.

Hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. acquired a new position in shares of Polarityte in the 1st quarter valued at $26,000. Citigroup Inc. acquired a new position in shares of Polarityte in the 1st quarter valued at $40,000. Glassman Wealth Services acquired a new position in shares of Polarityte in the 1st quarter valued at $45,000. Bank of Montreal Can acquired a new position in shares of Polarityte in the 1st quarter valued at $54,000. Finally, American International Group Inc. acquired a new position in shares of Polarityte in the 1st quarter valued at $69,000. 42.32% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This piece was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2019/06/12/polarityte-inc-nasdaqpte-director-steve-gorlin-sells-53700-shares.html.

Polarityte Company Profile

PolarityTE, Inc, a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services.

Featured Story: What is the significance of a dead cat bounce?

Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.